Effects of tadalafil—Type-V phosphodiesterase enzyme inhibitor—On rats with spinal trauma

References

• Tarlov IM, Klinger H. Spinal cord compression studies: III. Time limits for recovery after acute compression in dogs. AMA Arch Neurol Psychiatry 1954;71:588–97.
   PubMedGoogle Scholar
• Rivlin AS, Tator CH. Regional spinal cord blood flow in rats after severe cord trauma. J Neurosurg 1978;49:844–53.
   PubMed Web of Science ®Google Scholar
• Hoerlein BF, Redding RW, Hoff EJ, et al. Evaluation of dexamethasone, DMSO, mannitol, and solcoseryl in acute spinal cord trauma. J Am Anim Hosp Assoc 1983;19:216–26.
   Google Scholar
• Zileli M, Taniguchi M, Cedzich C, et al. Vestibulospinal evoked potential versus motor evoked potential monitoring in experimental spinal cord injuries of cats. Acta Neurochir (Wien) 1989;101:141–8.
   PubMedGoogle Scholar
• Tarlov IM. Spinal cord compression. Mechanism of paralysis and treatment. Springfield III, Charles C Thomas, 1957.
   Google Scholar
• Amar AP, Levy ML. Pathogenesis and pharmacological strategies for mitigating secondary damage in acute spinal cord injury. Neurosurgery 1999;44:1027–39.
   PubMed Web of Science ®Google Scholar
• Kaptanoglu E. Omurilik yaralanması ve patofizyolojisi, Temel nöroşirürji, Ed. Aksoy K, Palaoglu S, Pamir N, Tuncer R, 2. cilt, s;1144–55, Türk Nöroşirürji Derneği Yayınları, Ankara, 2005
   Google Scholar
• Amar AP, Levy ML. Pathogenesis and pharmacological strategies formitigating secondary damage in acute spinal cord injury. Neurosurgery 1999;44:1027–40.
   PubMed Web of Science ®Google Scholar
• Cumming MC, Winterford CM, Walker NI. Apoptosis. Am J Surg Pathol 1997;21:88–101.
   PubMedGoogle Scholar
• Lou J, Lenke LG, Ludwing FJ, et al. Apoptosis as a mechanism of neuronal cell death following acute experimental spinal cord injury. Spinal Cord 1998;36:683–90.
   PubMed Web of Science ®Google Scholar
• Lu J, Ashwell KW, Ken WS, et al. Advances in spinal cord injury: role of apoptosis. Spine 2000;25:1856–66.
   Google Scholar
• Popp AJ, Feustel P, Kimelberg HK. Pathophysiology of traumatic brain injury. In: Wilkins RH, Rengachary SS, eds. Neurosurgery, 2 ed. McGraw Hill: Philadelphia 1996;2623–2637.
   Google Scholar
• Dumont RJ, Verma S, Okonkwo DO, et al. Acute spinal cord injury, part II: contemporary pharmacotherapy. Clin. Neuropharmocol 2001;24:265–79.
   PubMed Web of Science ®Google Scholar
• Gale K, Kerasidis H, Wrathall JR. Spinal cord contusion in the rat: behavioral analysis of functional neurologic impairment. Exp Neurol 1985;88:123–34.
   PubMed Web of Science ®Google Scholar
• Yu K, Rong W, Li J, et al. Neurophysiological evidence of spa-red upper motor conduction fibers in clinically complete spinal cord injury: disomplete SCI in rats. J Neurol Sci 2001;189:23–36.
   PubMedGoogle Scholar
• Kaptanoğlu E, Beşkonaklı E, Solaroğlu I, et al. Magnesium sulfate treatment in experimental spinal cord injury: emphasis on vascular changes and early clinical results. Neurosurg Rev 2003;26:283–7.
   PubMed Web of Science ®Google Scholar
• Sakamoto A, Ohnishi ST, Ohnishi T, et al. Relationship between free radical production and lipid peroxidation during ischemia-reperfusion injury in the rat brain. Brain Res 1991;554:186–92.
   PubMed Web of Science ®Google Scholar
• Görgülü A, Kırış T, Ünal F, et al. Superoxide dismutase activity and the effects on NBQX and CPP on lipid peroxidation in experimental spinal cord injury. Res Exp Med 2000;199:285–93.
   PubMedGoogle Scholar
• Jeremy JY, Ballard SA, Naylor AM, et al. Effects of sildenafil, a type-5 cGMP phosphodiesterase inhibitor, and papaverine on cyclic GMP and cyclic AMP levels in the rabbit corpus cavernosum in vitro. Br J Urol 1997;79:958–63.
   PubMedGoogle Scholar
• Corbin JD, Turko IV, Beasley A, et al. Phosphorylation of phosphodiesterase-5 by cyclic nucleotide-dependent protein kinase alters its catalytic and allosteric cGMP-binding activities. Eur J Biochem 2000;267:2760–7.
   PubMedGoogle Scholar
• Lue TF. Erectile dysfunction. N Eng J Med 2000;342:1802–13.
   PubMed Web of Science ®Google Scholar
• Serarslan Y, Yonden Z, Ozgiray E, et al. Protective effects of tadalafil on experimental spinal cord injury in rats:J Clin Neurosci 2010;17:349–52.
   PubMed Web of Science ®Google Scholar
• McTigue DM. Potential therapeutic targets for pparγ after spinal cord injury. PPAR Res 2008:517162.
   Google Scholar
• Hall ED, Springer JE. Neuroprotection and acute spinal cord injury: a reappraisal. NeuroRx 2004;1:80–100.
   PubMedGoogle Scholar
• Fehlings MG, Nguyen DH. Immunoglobulin G: a potential treatment to attenuate neuroinflammation following spinal cord injury. J Clin Immunol 2010;1:S109–12
   Google Scholar
• Segal JL, Gonzales E, Yousefî S, et al. Circulating levels of IL-2R, ICAM-I, and IL-6 in spinal cord injuries. Arch Phys Med Rehabil 1997;78:44–7.
   PubMed Web of Science ®Google Scholar
• Tsai BM, Turrentine MW, Sheridan BC, et al. Differential effects of phosphodiesterase-5 inhibitors on hypoxic pulmonary vasoconstriction and pulmonary artery cytokine expression. Ann. Thorac. Surg 2006;81:272–8.
   PubMed Web of Science ®Google Scholar
• Rocha FA, Silva FS Jr, Leite AC, et al. Tadalafil analgesia in experimental arthritis involves suppression of intra-articular TNF release. Br J Pharmacol 2011;164:828–35.
   PubMed Web of Science ®Google Scholar
• Kaptanoğlu E, Beşkonaklı E, Okutan O, et al. Effect of magnesium sulfate in experimental spinal cord injury: evaluation with ultrastructural findings and early clinical results. J Clin Neurosci 2003;10:329–34.
   PubMed Web of Science ®Google Scholar